Discussing and prescribing expensive unfunded anticancer drugs in Australia

Masters, 2015, Clinical cancer advances 2015: annual report on progress against cancer from the American Society of clinical oncology, J Clin Oncol, 33, 786, 10.1200/JCO.2014.59.9746 Sullivan, 2011, Delivering affordable cancer care in high-income countries, Lancet Oncol, 12, 933, 10.1016/S1470-2045(11)70141-3 Berry, 2012, Variation and consternation: access to unfunded cancer drugs in Canada, J Oncol Pract, 8, 35, 10.1200/JOP.2011.000278 2017 2016 2016 Lewis, 2014, Dilemmas in the compassionate supply of investigational Cancer drugs, Intern Med J, 44, 841, 10.1111/imj.12530 Kaser, 2010, Communication about high-cost drugs in oncology--the patient view, Ann Oncol, 21, 1910, 10.1093/annonc/mdq068 2017 Stump, 2013, Cost concerns of patients with Cancer, J Oncol Pract, 9, 251, 10.1200/JOP.2013.000929 Berry, 2010, Continental divide? the attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs, J Clin Oncol, 28, 4149, 10.1200/JCO.2010.29.1625 Altomare, 2016, Physician experience and attitudes toward addressing the cost of cancer care, J Oncol Pract, 12, 247, 10.1200/JOP.2015.007401 Dimoska, 2008, Perceived difficulties in consulting with patients and families: a survey of australian cancer specialists, Med J Aust, 189, 612, 10.5694/j.1326-5377.2008.tb02211.x Chan, 2012, Less than ideal: how oncologists practice with limited drug access, J Oncol Pract, 8, 190, 10.1200/JOP.2011.000337 Mileshkin, 2009, To tell or not to tell: the community wants to know about expensive anticancer drugs as a potential treatment option, J Clin Oncol, 27, 5830, 10.1200/JCO.2009.22.7793 Thomson, 2006, Do oncologists discuss expensive anti-cancer drugs with their patients?, Ann Oncol, 17, 702, 10.1093/annonc/mdj136 Mellor, 2012, Access to anticancer drugs: many evidence-based treatments are off-label and unfunded by the Pharmaceutical Benefits Scheme, Intern Med J, 42, 1224, 10.1111/j.1445-5994.2012.02751.x Neumann, 2010, Cancer therapy costs influence treatment: a national survey of oncologists, Health Aff, 29, 196, 10.1377/hlthaff.2009.0077 Azad, 2013, Co-funded expanded access programmes for new oncology drugs: creating a two-tier system for australian cancer patients?, Intern Med J, 43, 843, 10.1111/imj.12126 Schrag, 2007, Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey, J Clin Oncol, 25, 233, 10.1200/JCO.2006.09.2437 Martins, 2012, Increasing response rates from physicians in oncology research: a structured literature review and data from a recent physician survey, Br J Cancer, 106, 1021, 10.1038/bjc.2012.28